CY2009017I2 - Μεθοδος για την παρασκευη 10, 11-διυδρο-10-υδροξυ-5η-διβενζο/β,f/αζεπινο-5-καρβοξαμιδιου και 10,11-διυδρο-10-οξο-5η-διβενζο/β,f/αζεπινο-5-καρβοξαμιδιου - Google Patents

Μεθοδος για την παρασκευη 10, 11-διυδρο-10-υδροξυ-5η-διβενζο/β,f/αζεπινο-5-καρβοξαμιδιου και 10,11-διυδρο-10-οξο-5η-διβενζο/β,f/αζεπινο-5-καρβοξαμιδιου

Info

Publication number
CY2009017I2
CY2009017I2 CY2009017C CY2009017C CY2009017I2 CY 2009017 I2 CY2009017 I2 CY 2009017I2 CY 2009017 C CY2009017 C CY 2009017C CY 2009017 C CY2009017 C CY 2009017C CY 2009017 I2 CY2009017 I2 CY 2009017I2
Authority
CY
Cyprus
Prior art keywords
azepino
dibenzo
carboxamide
dihydro
oxo
Prior art date
Application number
CY2009017C
Other languages
English (en)
Other versions
CY2009017I1 (el
Original Assignee
Bial - Portela & Ca., S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bial - Portela & Ca., S.A. filed Critical Bial - Portela & Ca., S.A.
Publication of CY2009017I1 publication Critical patent/CY2009017I1/el
Publication of CY2009017I2 publication Critical patent/CY2009017I2/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Catalysts (AREA)
CY2009017C 2001-05-25 2009-10-19 Μεθοδος για την παρασκευη 10, 11-διυδρο-10-υδροξυ-5η-διβενζο/β,f/αζεπινο-5-καρβοξαμιδιου και 10,11-διυδρο-10-οξο-5η-διβενζο/β,f/αζεπινο-5-καρβοξαμιδιου CY2009017I2 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0112812.3A GB0112812D0 (en) 2001-05-25 2001-05-25 Mthd for preparation of 10, 11-dihydro-10-hydroxy-5H-dibenz/B,F/azepine-5-c arboxamide and 10,11-dihydro-10-oxo-5H-dibenz/B,F/azepine-5-carb oxamide therefrom
PCT/GB2002/002356 WO2002096881A1 (en) 2001-05-25 2002-05-22 Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and 10,11-dihydro-10-0x0-5h-dibenz/b,f/azepine-5-carboxamide

Publications (2)

Publication Number Publication Date
CY2009017I1 CY2009017I1 (el) 2012-01-25
CY2009017I2 true CY2009017I2 (el) 2012-01-25

Family

ID=9915332

Family Applications (3)

Application Number Title Priority Date Filing Date
CY20081100998T CY1108345T1 (el) 2001-05-25 2008-09-17 Μεθοδος για την παρασκευη 10, 11-διυδρο-10-υδροξυ-5η-διβενζο/β,f/αζεπινο-5-καρβοξαμιδιου και 10,11-διυδρο-10-οξο-5η-διβενζο/β,f/αζεπινο-5-καρβοξαμιδιου
CY2009017C CY2009017I2 (el) 2001-05-25 2009-10-19 Μεθοδος για την παρασκευη 10, 11-διυδρο-10-υδροξυ-5η-διβενζο/β,f/αζεπινο-5-καρβοξαμιδιου και 10,11-διυδρο-10-οξο-5η-διβενζο/β,f/αζεπινο-5-καρβοξαμιδιου
CY20111100515T CY1111492T1 (el) 2001-05-25 2011-05-27 ΜΙΑ ΜΕΘΟΔΟΣ ΓΙΑ ΤΗΝ ΠΑΡΑΣΚΕΥΗ 10,11-ΔΙΥΔΡΟ-10-ΟΞΟ-5Η-ΔΙΒΕΝΖΟ[b,f]ΑΖΕΠΙΝΟ-5-ΚΑΡΒΟΞΑΜΙΔΙΟΥ

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY20081100998T CY1108345T1 (el) 2001-05-25 2008-09-17 Μεθοδος για την παρασκευη 10, 11-διυδρο-10-υδροξυ-5η-διβενζο/β,f/αζεπινο-5-καρβοξαμιδιου και 10,11-διυδρο-10-οξο-5η-διβενζο/β,f/αζεπινο-5-καρβοξαμιδιου

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY20111100515T CY1111492T1 (el) 2001-05-25 2011-05-27 ΜΙΑ ΜΕΘΟΔΟΣ ΓΙΑ ΤΗΝ ΠΑΡΑΣΚΕΥΗ 10,11-ΔΙΥΔΡΟ-10-ΟΞΟ-5Η-ΔΙΒΕΝΖΟ[b,f]ΑΖΕΠΙΝΟ-5-ΚΑΡΒΟΞΑΜΙΔΙΟΥ

Country Status (23)

Country Link
US (1) US7241886B2 (el)
EP (2) EP1399424B8 (el)
JP (3) JP4323309B2 (el)
KR (1) KR100931916B1 (el)
CN (2) CN1511141B (el)
AR (1) AR035460A1 (el)
AT (2) ATE400560T1 (el)
AU (2) AU2002307863B8 (el)
BR (1) BR0210019A (el)
CA (2) CA2750876C (el)
CY (3) CY1108345T1 (el)
CZ (1) CZ303130B6 (el)
DE (2) DE60227517D1 (el)
DK (2) DK1958938T3 (el)
ES (2) ES2305299T3 (el)
GB (1) GB0112812D0 (el)
HU (1) HU230019B1 (el)
LU (1) LU91603I2 (el)
MX (1) MXPA03010793A (el)
PL (1) PL215305B1 (el)
RU (2) RU2311411C2 (el)
SI (1) SI1399424T1 (el)
WO (1) WO2002096881A1 (el)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0303615D0 (en) * 2003-02-17 2003-03-19 Novartis Ag Use of organic compounds
ITMI20042230A1 (it) 2004-11-19 2005-02-19 Farchemia Srl Procedimento per la preparazione della 10,11-diidro-10 idrossi-5h-dibenz-b,f-azepin-5carbossiammide
ITMI20042291A1 (it) 2004-11-26 2005-02-26 Farchema S R L Procedimento per la preparazione della -s-piu-10,11-diidro-10-idrossi-5h-dibenz-b,f-azepin-5-carbossiammide
GB2422149A (en) * 2005-01-14 2006-07-19 Portela & Ca Sa Process for the preparation of 10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepine-5-carboxamide
US20060252745A1 (en) * 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
GB0515690D0 (en) 2005-07-29 2005-09-07 Portela & Ca Sa Asymmetric catalytic reduction
GB0517740D0 (en) * 2005-08-31 2005-10-12 Novartis Ag Organic compounds
GB0700773D0 (en) 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies
US8372431B2 (en) 2007-10-26 2013-02-12 Bial-Portela & C.A., S.A. Pharmaceutical composition comprising licarbazepine acetate
CA2769181C (en) 2009-07-27 2017-11-28 Bial-Portela & Ca., S.A. Use of 5h-dibenz / b, f/ azepine-5-carboxamide derivatives for treating fibromyalgia
US20150065704A1 (en) 2011-07-13 2015-03-05 Ketan Hirpara Process for the preparation and purification of eslicarbazepine acetate and intermediates thereof
WO2014049550A1 (en) 2012-09-26 2014-04-03 Ranbaxy Laboratories Limited Process for the preparation of oxcarbazepine and its use as intermediate in the preparation of eslicarbazepine acetate
CA2998886C (en) 2015-09-16 2023-05-16 PetaOmics, Inc. Methods and compositions for genomic target enrichment and selective dna sequencing
CN111943347B (zh) * 2020-07-16 2022-08-30 同济大学 一种铜离子活化过氧乙酸去除废水中卡马西平的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5439390B2 (el) * 1971-09-30 1979-11-27
BE789320A (fr) * 1971-09-30 1973-03-27 Takeda Chemical Industries Ltd Derives de dibenzoxirenazepine
CH633271A5 (en) * 1978-04-18 1982-11-30 Ciba Geigy Ag Process for the rearrangement of 10,11-epoxy-10,11-dihydro-5H-dibenz[b,f]azepines to give 10-oxo-10,11-dihydro-5H-dibenz(b,f)azepines
CH642950A5 (en) * 1979-10-30 1984-05-15 Ciba Geigy Ag Process for the preparation of 10-oxo-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide
IT1272897B (it) * 1995-01-13 1997-07-01 I F C Iniziative Finanziaarie Processo per la produzione di 10-oxo-10,11-diidro-sh- -dibenz(b,f) azepin-5-carbossiammide
PT101732B (pt) * 1995-06-30 1997-12-31 Portela & Ca Sa Novas di-hidrodibenzo<b,f>azepinas substituidas processo para a sua preparacao composicoes farmaceuticas que as contem e utilizacao dos novos compostos na preparacao de composicoes farmaceuticas empregues em doencas do sistema nervoso
PT101876B (pt) * 1996-05-27 1999-09-30 Portela & Ca Sa Novos derivados de 10,11-di-hidro-10-oxo-5h-dibenzo(b,f)azepina-5-carboxamida
AT408224B (de) 1999-03-15 2001-09-25 Dsm Fine Chem Austria Gmbh Verfahren zur herstellung von oxcarbazepin

Also Published As

Publication number Publication date
MXPA03010793A (es) 2004-07-01
ES2305299T3 (es) 2008-11-01
CZ20033203A3 (cs) 2004-06-16
EP1399424B8 (en) 2008-10-01
BR0210019A (pt) 2004-08-10
DE60239842D1 (de) 2011-06-01
JP5280252B2 (ja) 2013-09-04
HUP0400296A2 (hu) 2004-08-30
LU91603I2 (fr) 2009-10-28
RU2003137224A (ru) 2005-05-27
CA2750876C (en) 2014-10-28
ATE506351T1 (de) 2011-05-15
CA2448094C (en) 2011-11-01
CN1511141A (zh) 2004-07-07
US7241886B2 (en) 2007-07-10
JP2009167194A (ja) 2009-07-30
KR20040030626A (ko) 2004-04-09
RU2449992C2 (ru) 2012-05-10
RU2007120532A (ru) 2008-12-10
US20040158060A1 (en) 2004-08-12
CY1111492T1 (el) 2015-08-05
JP2004532263A (ja) 2004-10-21
CN1511141B (zh) 2011-06-08
PL215305B1 (pl) 2013-11-29
CY2009017I1 (el) 2012-01-25
PL366993A1 (en) 2005-02-07
CA2448094A1 (en) 2002-12-05
WO2002096881A8 (en) 2003-02-27
ATE400560T1 (de) 2008-07-15
EP1399424B1 (en) 2008-07-09
CN101172967A (zh) 2008-05-07
SI1399424T1 (sl) 2008-10-31
JP2009057376A (ja) 2009-03-19
CY1108345T1 (el) 2012-01-25
HUP0400296A3 (en) 2008-03-28
AU2007221834B2 (en) 2009-02-05
DE60227517D1 (de) 2008-08-21
AU2007221834A1 (en) 2007-10-25
EP1958938B1 (en) 2011-04-20
DK1958938T3 (da) 2011-07-25
DK1399424T3 (da) 2008-09-08
EP1958938A2 (en) 2008-08-20
JP4323309B2 (ja) 2009-09-02
AU2002307863B2 (en) 2007-09-27
ES2362688T3 (es) 2011-07-11
GB0112812D0 (en) 2001-07-18
RU2311411C2 (ru) 2007-11-27
CA2750876A1 (en) 2002-12-05
AR035460A1 (es) 2004-05-26
EP1399424A1 (en) 2004-03-24
AU2002307863B8 (en) 2007-10-18
CZ303130B6 (cs) 2012-04-18
KR100931916B1 (ko) 2009-12-15
EP1958938A3 (en) 2008-09-03
WO2002096881A1 (en) 2002-12-05
HU230019B1 (hu) 2015-05-28

Similar Documents

Publication Publication Date Title
CY2009017I1 (el) Μεθοδος για την παρασκευη 10, 11-διυδρο-10-υδροξυ-5η-διβενζο/β,f/αζεπινο-5-καρβοξαμιδιου και 10,11-διυδρο-10-οξο-5η-διβενζο/β,f/αζεπινο-5-καρβοξαμιδιου
CY2012032I1 (el) Ενωσεις 1,2-διυδροπυριδινης, διεργασια για την παρασκευη των ιδιων και χρηση εξ αυτων
CY2018010I1 (el) Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
CY2014038I1 (el) Αντι-il-6 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
CY2007029I1 (el) Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων
NO20040198L (no) Dolastatin 10 derivater
ITRM20020264A0 (it) Articolo assorbente e procedimento per la sua fabbricazione.
CY2013003I2 (el) Φωσφονοκεφεμικα παραγωγα, διαδικασια για την παρασκευη τους, και χρηση αυτων
NO20042410L (no) Sammensetning som omfatter angiopoietinliknende protein 3, ANGPTL3 og fremgangsmate til anvendelse av samme
FI20012426A (fi) Komposiitti-nonwoven, sen käyttö ja menetelmä sen valmistamiseksi
ATE303388T1 (de) Substituierte 2-pyridinyl-6,7,8,9- tetrahydropyrimidoc1,2-aöpyrimidin-4-on- und 7- pyridinyl-2,3-dihydroimidazo-c1,2-aöpyrimidin- 5(1h)onderivate
IL161893A0 (en) 5-Phenylpyrimidines, agents comprising the same, method for production and use thereof
FI20010075A (fi) Terveysvaikutteinen tuote ja menetelmä
FI20000410A0 (fi) Jäähdytyselementti ja menetelmä jäähdytyselementin valmistamiseksi
FI20012594A0 (fi) Parannettu menetelmä asiakaskohtaisen tuotteen valmistamiseksi ja asiakaskohtainen tuote
MA27240A1 (fr) Derives d&#39;imidazoquinoleine
HUP0401577A3 (en) Process for the preparation of 2,4-didezoxyhexoses and 2,4,6-tridezoxyhexoses
PT1408035E (pt) Metodo de preparacao de derivativos de 1.5-diaril-3-trifluorometilo-delta2-pirazolinas que sejam racemicos e enanciomericamente puros
DE50107204D1 (de) 8beta-substituierte-11beta-pentyl-und 11beta-hexyl-estra-1,3,5(10)-trienderivate
FI20010730A0 (fi) Menetelmä hoitotuotteen valmistamiseksi ja hoitotuote
IS7131A (is) Nýjar 2,4-díamínóþíasól afleiður
ITMI20010851A0 (it) Composizione antiparassitaria e metodo di trattamento antiparassitario utilizzante la composizione
SE0103455D0 (sv) The W/F/T-Sens 1
IT1318371B1 (it) Processo per la preparazione di eterocicli.
ITMI20011344A0 (it) Procedimento per la preparazione di 1,3-diossolan-2-oni